MA-CLS-2 Cells
CAD$897.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MA-CLS-2 cell line was established from the pleural effusion of a female patient diagnosed with breast ductal carcinoma. This cell line originates from a human breast tumor and specifically represents a pleural metastasis, which is often associated with advanced stages of cancer. The original tumor was classified as pT1 NO GII, indicating a primary tumor of limited size (T1), with no regional lymph node metastasis (N0), and graded as moderately differentiated (GII). These characteristics suggest that the tumor was relatively early-stage but had already disseminated to the pleural cavity, a complication that significantly impacts patient prognosis. MA-CLS-2 is particularly valuable for studying the metastatic processes of breast cancer, especially those involving pleural effusion, which can provide insights into the mechanisms of tumor spread and potential therapeutic targets. The cell line offers a model to investigate the interactions between metastatic breast cancer cells and the pleural environment, facilitating research into novel interventions aimed at preventing or treating metastatic disease. As a model of a pleural metastasis derived from a ductal carcinoma, MA-CLS-2 also allows for the examination of drug responses in the context of metastatic breast cancer. |
|---|---|
| Organism | Human |
| Tissue | Breast |
| Disease | Ductal carcinoma |
| Metastatic site | Pleural effusion |
| Synonyms | MACLS-2, MACLS2 |
Characteristics
| Age | 47 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Monolayer, adherent |
Regulatory Data
| Citation | MA-CLS-2 (Cytion catalog number 300271) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_4571 |
Biomolecular Data
| Tumorigenic | Yes, in nude mice |
|---|---|
| Ploidy status | Aneuploid |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | Fast |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|